weight loss drug news today glp-1 october 2025 obesity A nice article in The Hindu highlights the GLP-1 Pipeline Update: November 2025

Duoject-B Duoject-B for use in neuromuscular disorders, anaemias and poor nutrition

Antibacterial Activity of Exogenous Glutathione and Its Synergism on Antibiotics in Methicillin-Associated Multidrug Resistant Clinical Isolates of Staphylococcus aureus 1

Direct SlC7A11 overexpression in cardiac myocytes boosted GSH levels and reduced cardiac ferroptosis and injury, suggesting that it is feasible to fortify GSH levels by increasing SLC7A11 [76]

For many companies, the safest path is to exit GLP-1 sales and refocus on compounds with lower regulatory and IP risk

People wondering whether GLP-1 is the same as Ozempic should understand that Ozempic is one specific GLP-1 agonist among several, each with its own pharmacological profile and clinical data